Analysis of 18F-XTR006 PET Imaging in Cognitively Normal Subjects, and Patients With MCI and AD
Clinical trial NCT07115238 · RECRUITING
Trial details
- NCT number
- NCT07115238
- Sponsor
- Sinotau Pharmaceutical Group
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-20
- Primary completion
- 2025-12-31
- Enrollment
- 354
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.